✦HEALTH · 30% off Purgo Labs✦
BPC-157+TB-500Preclinical only

BPC-157 and TB-500: Stack Guide

BPC-157 and TB-500 (Thymosin Beta-4) are the two most studied peptides for tissue repair and recovery. They work through distinct but complementary mechanisms — BPC-157 primarily promotes angiogenesis and GI healing, while TB-500 promotes actin polymerization and systemic tissue remodeling. In animal models they act on different parts of tissue repair; no study has tested the two together in people.

For research and educational purposes only. Not medical advice.

Mechanism of Interaction

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from human gastric juice. It promotes angiogenesis via VEGF upregulation, modulates nitric oxide synthesis, and accelerates tendon, ligament, and GI mucosal healing. TB-500 is a synthetic fragment of Thymosin Beta-4 that promotes actin polymerization, reduces inflammation, and enhances cell migration — particularly in muscle, tendon, and cardiac tissue.

Research Evidence

Both compounds have extensive preclinical evidence in rodent models. BPC-157 has demonstrated accelerated healing in over 100 animal studies across multiple tissue types. TB-500 has shown efficacy in cardiac repair models and tendon healing. There are no human trials of BPC-157 or of the TB-500 fragment, alone or combined (full-length thymosin beta-4 has been in human trials, mainly as an eye drop). The idea that the two complement each other is inferred from separate animal studies; it has not been tested.

Is there a combined schedule?

No published trial has tested BPC-157 and TB-500 together in people, and the animal studies behind each compound used model-specific amounts and routes that do not translate into a human figure. The combined "stack" schedules that circulate online come from forums, not from research. Compound Review does not publish dosing protocols; both compounds are sold for laboratory research only and are not for human or animal consumption.

Safety Considerations

Both compounds have favorable preclinical safety profiles with no significant toxicity observed in animal studies. The combination does not appear to produce additive adverse effects. The main consideration is that neither compound has been studied in human clinical trials, so all use is considered research-only.

Frequently Asked Questions

Why are BPC-157 and TB-500 discussed together?

Because in animal models they act on tissue repair through different routes: BPC-157 is studied mainly for local effects on blood-vessel growth and gut and tendon tissue, TB-500 for actin binding and cell migration. That difference is why people describe them as complementary. No published study has tested the two together in people, so the combination has no human evidence behind it. Both are sold for laboratory research only and are not for human or animal consumption.

What is the difference between BPC-157 and TB-500?

BPC-157 is a 15-residue fragment of a gastric protein, studied in rodents mainly for angiogenesis and gut, tendon and ligament tissue. TB-500 is the actin-binding fragment of thymosin beta-4 (vendors also sell the full-length protein under the name), studied for cell migration and tissue remodeling, including cardiac tissue in animal models. Their mechanisms differ; neither has an approved human use.

Is there evidence about mixing BPC-157 and TB-500 in one solution?

No stability study we know of has tested the two peptides combined in one solution, so how long such a mixture stays intact is unknown. That is a separate question from compatibility in a vial on a lab bench, and nothing on this site is guidance on administering either compound. Pre-mixed blends sold by vendors carry the same gap: check whether the certificate covers the blend itself or only the separate raw materials.

Is there an established schedule for BPC-157 and TB-500?

No. The 4-to-12-week 'cycles' that circulate online come from forums, not trials; animal studies used durations chosen for each model. Compound Review does not publish dosing or cycling protocols.

Research Source

Purgo Labs provides research-grade peptides with independent third-party COAs and >99% purity verification.

Shop Purgo Labs

Related Guides